IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport

By rosaguerrero • July 28, 2022

Boado RJ. IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. Pharmaceutics. 2022 Jul 15;14(7):1476. doi: 10.3390/pharmaceutics14071476. PMID: 35890374; PMCID: PMC9322584.

Tags: Alzheimer’s disease, blood–brain barrier, decoy receptors, fusion proteins, insulin receptor, lysosomal storage disorders, monoclonal antibody, neurotrophic factors, Parkinson’s disease, protein-based therapy, Publications, transferrin receptor

Examining the Relationship Between Anthropometric and Body Composition measures with Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis

Haidar A, Kronmal R, Allison M, Watson K, Srikanthan P, Horwich T. Examining the Relationship Between Anthropometric and Body Composition measures with Coronary Heart Disease[...]

The pharmacist as a key member of the kidney care team

Schumacher C, Duru OK, Maripuri S, Roberts G, Van Dril E. The pharmacist as a key member of the kidney care team. Am J Health[...]

Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV

Daar ES, Orkin C, Sax PE, Hagins D, Pozniak A, Workowski K, Brinson C, Tiraboschi JM, Liu H, Deaton C, Cohen C, Madera S, Hindman[...]